Collaborative Partners

EMORY UNIVERSITY 

min-javed-butler  

Dr. Javed Butler
Professor of Medicine
Professor of Medicine, Director Heart Failure Research

Emory University Hospital Midtown
550 Peachtree St
Atlanta, GA 30308

Tel : (404) 686-7885
@ : This email address is being protected from spambots. You need JavaScript enabled to view it.  

Dr. Javed Butler is Professor of Medicine at the Emory University and the Deputy Chief Science Officer for the American Heart Association. After graduating from the Aga Khan University, Dr. Butler completed his residency and chief residency from Yale University, Masters in Public Health from Harvard University, and cardiology fellowship from Vanderbilt University. He subsequently also completed an advanced heart failure and cardiac transplantation fellowship from Vanderbilt University and cardiac Imaging training at the Massachusetts General Hospital. He is board certified in Internal Medicine, Cardiovascular Diseases, Advanced Heart Failure, and Nuclear Cardiology.

He serves various editorial responsibilities for the Journal of the American College of Cardiology, Journal of Cardiac Failure, American Heart Journal, Current Heart Failure Reviews, Heart Failure Clinic, and Congestive Heart Failure. He serves on the American College of Cardiology/American Heart Association as well as the Heart Failure Society of America's Heart Failure Guidelines Committees. He has published over 150 original research papers. He has served in various committees for multiple professional organizations, the National Institutes of Health, and The Joint Commission. Dr. Butler is the principle investigator for the National Institutes of Health funded Heart Failure Clinical Trials Network at Emory. He has participated in over 50 clinical trials.


 Imperial College London

Imperial College, London (UK) will contribute to the provision of data and biological samples from the ASCOT Trial of well characterized patients and subjects enrolled in this large-scale multicenter clinical trial in patients with high CV risk. It will also participate to the design of analysis plan and to the drafting scientific reports derived from the analysis of these samples. Pr Sever will serve in a scientific advisory role on the data analysis phase in the identification of biomarker fingerprints of heart failure.

 

 min-peter-sever  

Peter Sever
Professor of Clinical Phamacology and Therapeutics
Honorary Consultant Physician at the Imperial College Healthcare NHS Trust 
Co-Director of the International Centre for Circulatory Health

International Centre for Circulatory Health, 
Imperial College London
59 North Wharf Rd 
London W2 1LA
UK

Tel : +44 (0)20 7594 1100
@ : This email address is being protected from spambots. You need JavaScript enabled to view it.  

 

 Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London and Honorary Consultant Physician at the Imperial College Healthcare NHS Trust.  He is co-Director of the International Centre for Circulatory Health and Head of the Disease Prevention Section of the National Heart and Lung Institute, Imperial College London.  In 2009, was appointed as a Senior Investigator of the National Institute for Health Research.

Professor Sever’s research interests include the pathophysiology of vascular disease, the evaluation of antihypertensive drug therapy and the impact of multiple risk factor intervention for the prevention of cardiovascular disease.

 

After graduating from the University of Cambridge, Professor Sever completed his training at St Mary’s Hospital Medical School in London.  He became an Honorary Consultant Physician and Senior Lecturer in Medicine at St Mary’s Hospital in 1976.  In 1980, he was appointed Professor of Clinical Pharmacology and Therapeutics at St Mary’s Hospital Medical School, which was subsequently incorporated into the Imperial College School of Medicine. 

Professor Sever is Joint Editor-in-Chief of the Journal of the Renin-Angiotensin-Aldosterone System.  Professor Sever is a past President of the British Hypertension Society and the European Council for Blood Pressure and Cardiovascular Research and past Chairman of the Fellowships Committee of the British Heart Foundation.  He is also a Fellow of the European Society of Cardiology.  In 2010, he was presented with the AstaZeneca Award from the International Society for Hypertension for his contribution to the clinical pharmacology and therapy of arterial hypertension.

 


Steno Diabetes Center

Steno Diabetes Center (Novo Nordisk) will contribute to the provision of data and biological samples from the ongoing PRIORITY Trial of well characterized patients enrolled in this large-scale multicenter clinical trial in patients with diabetes. This at risk patients are at risk of developing new onset heart failure. Pr Rossig will also participate to the design of analysis plan and to the drafting scientific reports derived from the analysis of these samples and serve in a scientific advisory role on the data analysis phase in the identification of biomarker fingerprints of heart failure.

The main objective of the PRIORITY trial is very complementary and similar to the HOMAGE trial. It aims to develop an intervention strategy to prevent development of diabetic nephropathy based on the application of the urinary proteomics test to identify high risk patients and subsequent treatment by the use of aldosterone blockade as a means to reduce progression to microalbuminuria.

 

 min-peter-rossing  

Peter Rossing, MD, DMSc
Professor, Chief Physician
Director of Research of the Steno Diabetes Center

Steno Diabetes Center 
Niels Steensens Vej 2
2820 Gentofte
Denmark

Tel : +45 4443 7310
@ : pThis email address is being protected from spambots. You need JavaScript enabled to view it.  

Peter Rossing has since 2007 been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes. Since 2010 Head of Research at SDC and from 2012 adjunct professor at University of Aarhus and University of Copenhagen in diabetic angiopathy. The particular focus has been on diabetic nephropathy and macroangiopathy. The research has included prevention and treatment of these complications. Furthermore there has been focus on risk prediction and biomarker discovery. Coordinator of the EU FP7 sponsored project PRIORITY for early prevention of diabetic nephropathy. PR has co-authored >200 papers, 29 as a first author. 139 of the papers are original and peer reviewed contributions, 20 are reviews or invited chapters, and his h-index is 43. PR has received several national and international awards including The Minkowski prize from the EASD in 2005 and the Novarits Young Investigator Diabetes Prize 2009. 

Specialist in Internal medicine and endocrinology October 2004

DMSc at Univ of Copenhagen 1998 “Promotion, prediction and prevention of progression in diabetic nephropathy”

Professional Positions

2008 - Danish Endocrine Society – president 2012.


 2009 - Danish Hypertension Society – member of the board


 2006-2010 - European Diabetic Nephropathy Study group – member of the board


2011 - Co-Chair of Danish National Indicator Project for Diabetes

 

Positions

11.02.91 - 30.09.94                               Hvidöre Hospital/Steno Diabetes Center                                                                                  


01.10.94 - 29.02.96                               Steno Education Center, Course coordinator                


01.03.96-31.08.96                                 Sygehuset Øresund, Helsingør, Surgery  (registrar)       


01.09.96-28.2.97                                   Hillerød sygehus Med dept B (registrar)           


01.03.97-31.08.97                                 GP Lægehuset i Frederikssund                        


01.09.97-30.09.97                                 Registrar: Med dept Roskilde Amtssygehus     


01.10.97-30.09.98                                 Registrar: Med dept F KAS Herlev                   


01.10.98-31.08.99                                 Registrar: Med dept F KAS Gentofte               


01.09.99-31.08.00                                 Registrar: Med dept CF KAS Glostrup             


01.09.00-28.02.01                                 Registrar: Dept of nephrology  KAS Herlev      


01.03.01-31.08.01                                 Registrar: Dept of Oncology KAS Herlev                     


01.09.01-31.03.02                                 Senior, Dept of Medicine F KAS Gentofte                   


01.04.02-31.12.04                                 Senior, Dept of Endocrinology, University of Copenhagen, Herlev Hospital                                                                                              


01.01.05-31.12.2006                            Senior registrar Steno Diabetes Center (SDC), 


01.01.2007-                                            Chief physician and manager of complications research SDC


01.01.2010-                                            Head of Research SDC,

                                                                  Adjunct professor in diabetic angiopathy, HEALTH University of Aarhus,

                                                                  Novo Nordisk Foundation Center for Basic Metabolic Research,

                                                                  University of Copenhagen

 

 

 

Search